Kyto Technology and Life Science Inc KBPH:OTCQB

RT Quote | Exchange | USD
Last | 11/19/20 EST
2.00UNCH (UNCH)
52 week range
1.75 - 2.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.00
  • 52 Week High2.50
  • 52 Week High Date03/03/20
  • 52 Week Low1.75
  • 52 Week Low Date09/08/20
  • Market Cap19.60M
  • Shares Out9.80M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-40.98
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-892,780.00
  • ROE (MRQ)-1.88%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-3,019.82%
  • Debt To Equity (MRQ)0.13%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kyto Technology and Life Science Inc News

There is no recent news for this security.

Latest KBPH News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kyto Technology and Life Science, Inc., formerly Kyto Biopharma, Inc., seeks to develop a specialized vehicle for early stage technology and life science companies. The Company operates as a mentor, advisor, external manager and investor for selected privately held companies in the United States of America, Canada and Israel. The Company’s portfolio includes CNote Group, Inc. (CNote), Exodos/Achelios Therapeutics, Inc. (Achelios), Seal Rock Therapeutics, Inc., and Crater, LLC...
Paul Russo
Chairman
Simon Westbrook
Chief Financial Officer
Address
13050 La Paloma Rd
Los Altos Hills, CA
94022-3333
United States